Rchr
J-GLOBAL ID：200901010516120952
Update date: Sep. 29, 2023
Nishikawa Tomoyuki
ニシカワ トモユキ | Nishikawa Tomoyuki
Affiliation and department：
Research field (2)：
Biomaterials
, Biomedical engineering
Research keywords (2)：
Gene Therapy Science
, 遺伝子治療学
Research theme for competitive and other funds (4)：
- HVJ-エンベロープを用いた遺伝子導入法の開発
- HVJ-エンベロープベクターを用いたcDNAライブラリーのスクリーニング系の開発
- Development of Gene Transfer System by Using HVJ-Envelope Vector.
- Development of cDNA Library Screening System by Using HVJ-Envelope Vector.
Papers (32)：
-
Hiroki Hayashi, Jiao Sun, Yuka Yanagida, Takako Otera, Jiayu A. Tai, Tomoyuki Nishikawa, Kunihiko Yamashita, Naoki Sakaguchi, Shota Yoshida, Satoshi Baba, et al. Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction. Scientific Reports. 2023. 13. 1
-
Chin Yang Chang, Jiayu A. Tai, Yuko Sakaguchi, Tomoyuki Nishikawa, Yayoi Hirayama, Kunihiko Yamashita. Enhancement of polyethylene glycol-cell fusion efficiency by novel application of transient pressure using a jet injector. FEBS Open Bio. 2023. 13. 3. 478-489
-
Hiroki Hayashi, Jiao Sun, Yuka Yanagida, Takako Otera, Miwa Sasai, Chin Yang Chang, Jiayu A. Tai, Tomoyuki Nishikawa, Kunihiko Yamashita, Naoki Sakaguchi, et al. Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant. Scientific Reports. 2022. 12. 1
-
Tomoyuki Nishikawa, Chin Yang Chang, Jiayu A Tai, Hiroki Hayashi, Jiao Sun, Shiho Torii, Chikako Ono, Yoshiharu Matsuura, Ryoko Ide, Junichi Mineno, et al. Immune response induced in rodents by anti-CoVid19 plasmid DNA vaccine via pyro-drive jet injector inoculation. Immunological medicine. 2022. 1-14
-
Yi Chun Pan, Tomoyuki Nishikawa, Chin Yang Chang, Jiayu A. Tai, Yasufumi Kaneda. CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy. Molecular Therapy - Oncolytics. 2021. 20. 175-186
ｍore...
MISC (12)：
-
Tomoyuki Nishikawa, Li-Wen Liu, Yasufumi Kaneda. In Vitro-Synthesized Sendai Virus RNA Fragments Induced Antitumor Immunity and Cancer Cell-Selective Apoptosis. MOLECULAR THERAPY. 2016. 24. S59-S60
-
Tomoyuki Nishikawa, Yasufumi Kaneda. Cancer Immunotherapy Using a Cancer-Targeting Platelet Vector Incorporating Viral Particles. MOLECULAR THERAPY. 2014. 22. S244-S244
-
Tomoyuki Nishikawa, Yasufumi Kaneda. Systemic Administration of Platelet Vector Containing Inactivated Sendai Virus Particle Eradicates Melanoma in Mice. MOLECULAR THERAPY. 2012. 20. S264-S264
-
Hironori Nakagami, Tomoyuki Nishikawa, Katsuto Tamai, Yasufumi Kaneda. MODIFICATION OF NOVEL ANGIOGENIC PEPTIDE, AG-30, TOWARD CLINICAL APPLICATION. JOURNAL OF GENE MEDICINE. 2010. 12. 12. 1022-1022
-
Tomoyuki Nishikawa, Hironori Nakagami, Ryuichi Morishita, Akito Maeda, Katsuto Tamai, Yasu-fumi Kaneda. ANALYSIS ON SIGNAL PATHWAY OF AN ANTIMICROBIAL AND ANIGOGENIC PEPTIDE, AG-30, STIMULATED ENDOTHELIAL CELLS. JOURNAL OF GENE MEDICINE. 2010. 12. 12. 1027-1027
ｍore...
Patents (4)：
-
免疫賦活用組成物(長鎖:sl-RNA-45-57)
-
血管新生誘導剤及びそれに用いられるポリペプチド
-
新規ポリペプチドおよびそれを有効成分として含有する抗菌剤
-
血管内皮細胞増殖促進遺伝子
Education (3)：
- - 2006 Osaka University
- - 2000 ニューヨーク大学大学院 生物科学研究科 応用DNA組み換え技術
- - 1997 フィラデルフィア大学 生化学部
Professional career (3)：
- MASTER OF SCIENCE (Osaka University)
- 修士 (ニューヨーク大学)
- 学士 (フィラデルフィア大学)
Committee career (1)：
- 2021/09 - 現在 日本遺伝子細胞治療学会 評議員
Awards (3)：
- 2015/05 - 日本遺伝子細胞治療学会 研究奨励賞
- 2006/07 - 日本遺伝子細胞治療学会 若手奨励賞
- 1997/05 - American Chemical Society Outstanding Paper in Separation Science
Association Membership(s) (5)：
ヨーロッパ遺伝子細胞治療学会
, アメリカ遺伝子細胞治療学会
, 日本がん免疫学会
, 日本癌学会
, 日本遺伝子細胞治療学会
